Bas Trietsch is the Chief Technology Officer (CTO) at MIMETAS, a leading biotech company specializing in organ-on-a-chip technology. As the CTO, Bas Trietsch is responsible for overseeing the technological aspects of MIMETAS' organ-on-a-chip platforms and driving innovation in this field. Under Bas Trietsch's guidance, MIMETAS has made significant advancements in the field of organ-on-a-chip technology, enabling more efficient drug discovery and personalized medicine applications. By integrating cutting-edge technologies and leveraging AI algorithms, MIMETAS aims to revolutionize the pharmaceutical industry and accelerate the development of safer and more effective drugs.